AllianceBernstein’s Disc Medicine IRON Stock Holding History

AllianceBernstein’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.22M	Buy	34,670 +10,130	+41%	+$696K	﹤0.01%	1986
2026 Q1	$1.95M	Hold	24,540	–	–	﹤0.01%	2016
2025 Q4	$1.95M	Hold	24,540	–	–	﹤0.01%	2020
2025 Q3	$1.62M	Buy	24,540 +400	+2%	+$23.8K	﹤0.01%	2123
2025 Q2	$1.28M	Buy	24,140 +3,080	+15%	+$145K	﹤0.01%	2166
2025 Q1	$1.05M	Hold	21,060	–	–	﹤0.01%	2218
2024 Q4	$1.34M	Hold	21,060	–	–	﹤0.01%	2170
2024 Q3	$1.03M	Hold	21,060	–	–	﹤0.01%	2311
2024 Q2	$949K	Sell	21,060 -475,821	-96%	-$16.2M	﹤0.01%	2332
2024 Q1	$30.9M	Buy	496,881 +133,796	+37%	+$8.67M	0.01%	733
2023 Q4	$21M	Buy	363,085 +353,955	+3,877%	+$18.1M	0.01%	868
2023 Q3	$429K	Buy	9,130 +1,850	+25%	+$92.5K	﹤0.01%	2648
2023 Q2	$323K	Buy	+7,280	New	+$258K	﹤0.01%	2833

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AllianceBernstein's IRON Position: Q2 2026 in Review

AllianceBernstein increased its Disc Medicine (IRON) stake by 41% in Q2 2026, buying an estimated $696K and bringing the position to 34,670 shares worth $2.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1986.

AllianceBernstein first reported a position in IRON in Q2 2023 and has held it in 13 quarters since. The position peaked at $30.9M in Q1 2024. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

AllianceBernstein held 34,670 shares of Disc Medicine worth $2.22M as of Q2 2026.
AllianceBernstein bought 10,130 Disc Medicine shares in Q2 2026, an estimated $696K.
Disc Medicine made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #1986 holding.
AllianceBernstein first reported a position in Disc Medicine in Q2 2023 and has held it in 13 quarters since.
AllianceBernstein's Disc Medicine position peaked at $30.9M in Q1 2024.
216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.